Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07348289 · ClinicalTrials.gov registry record
PIVO Use for Blood Cultures in the Emergency Department
A clinical trial of Sepsis and Emergency Medicine, sponsored by Intermountain Health Care.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT07348289 is a study of Sepsis and Emergency Medicine that is actively recruiting participants, run by Intermountain Health Care. The registered enrollment target is 10,000 participants, above the 6,454-participant average among 90 other Sepsis trials with a reported enrollment target (55% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07348289, a study of Sepsis and Emergency Medicine, is actively recruiting participants, sponsored by Intermountain Health Care.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will implement a protocol for use of the PIVO device for blood culture collection in the emergency department. This protocol utilizes the device in various scenarios to reduce needlesticks while allowing for accurate and appropriate assessment of potential pathogens in the bloodstream. The study team will train staff on use of the device then monitor utilization and contamination rates among emergency department patients.
Conditions Studied
Interventions
- DEVICE PIVO device, a needle-free blood draw device
Study Locations (1)
Utah
- Park City Hospital - Park City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2027-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07348289
The ClinicalTrials.gov registry entry for NCT07348289 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 6,454-participant average among 90 other Sepsis trials with a reported enrollment target (55% higher). The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which PIVO device, a needle-free blood draw device is the first listed.
NCT07348289 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT07348289 about?
NCT07348289 is a clinical study titled "PIVO Use for Blood Cultures in the Emergency Department". The investigators will implement a protocol for use of the PIVO device for blood culture collection in the emergency department. This protocol utilizes the device in various scenarios to reduce needlesticks while allowing for accurate and appropriate assessment of potential pathogens in the bloodstr...
What is the current status of trial NCT07348289?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2025-10-01. Estimated completion is 2027-07-31.
What conditions does trial NCT07348289 study?
This clinical trial studies the following conditions: Sepsis, Emergency Medicine, Device Performance.
What interventions are being tested in trial NCT07348289?
The interventions under investigation include: PIVO device, a needle-free blood draw device (DEVICE).
Who is sponsoring clinical trial NCT07348289?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07348289 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.